Investor Presentaiton slide image

Investor Presentaiton

Life sciences¹ Viread, a successful antiviral drug for the treatment of HIV/AIDS has been developed at the Czech Academy of Science's Institute of Organic Chemistry and Biochemistry. The country offers a growing network of re- search clusters, state-of-the-art research facili- ties, attractive locations for manufacturing and contract R&D operations plus effective patent protection. The government's policy goals in- clude the continuation of R&D support. GMP, GLP and GCP standards have been adopted. Current successful investors: Sanofi, TEVA, Lonza, Otsuka Nanotechnologies and materials¹ The Czech Republic is proud of its network of collaborating business companies which has emerged around top research institutions involved in the most prestigious projects. CEITEC, the Regional Centre of Advanced Tech nologies and Materials, the Technical Univer- sity of Liberec are undisputedly world-class centres of nanotechnology research. They are supported by a state-of-the-art research infra- structure and by the Czech Nanotechnology Cluster and Nanotechnology for Society fund- ing programme. Current successful investors: Microsoft, Skype, NetSuite, Tieto, Red Hat, So larWinds and IBM 15 1 Investment Climate in the Czech Republic, 2015, CzechInvest
View entire presentation